Mundipharma

Concept ideas & design

Background

Diabetic nephropathy narrows options, for patients and clinicians alike. As it progresses, the risk of cardiovascular complications rises, and the window for effective intervention closes. Catch it before that happens. Regular screening for eGFR and ACR is the clearest path to early detection and the best chance of changing the outcome.